Jury rules for Pfizer in Prempro case

A Wyeth menopause drug did not cause a woman's breast cancer, and the drugmaker is not liable for damages, a Philadelphia jury found yesterday--two days after another local jury found against parent company Pfizer and levied nearly $10 million in damages. Report

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

Amarin had big plans for Vascepa after a big label expansion last year, but it lost a patent fight—and now a generic has won FDA approval.

Intercept Pharmaceuticals, eager to market its potential nonalcoholic steatohepatitis medicine obeticholic acid, will have to keep waiting.